Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06923930 · ClinicalTrials.gov registry record · NA
Impact of a Cueing Device on Upper Extremity Muscle Strength in Swimmers
A NA study, sponsored by University of South Alabama.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT06923930: Completed NA study, sponsored by University of South Alabama.
NCT06923930 is a NA study that has completed, run by University of South Alabama. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06923930, a NA study, has completed, sponsored by University of South Alabama.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The goal of this study is to find out if a tool called an external cueing device (ECD) can help young swimmers improve their shoulder function. An ECD is a tool that limits arm movement and gives the swimmer a target to focus on while doing exercises. The main questions this study will answer are: * Does using an ECD during certain exercises improve muscle strength? * Does using an ECD while exercising help with shoulder stability? Participants will: * Test their shoulder muscle strength and stability at the beginning of the study. * Complete 8 exercises as part of their regular dry-land training program for 6 weeks. * Repeat the same tests after 3 weeks and again at the end of the study.
Primary Outcome
Handheld dynamometer assessment of force production times lever arm distance (Newton.meters) of prone shoulder elevation in 180 degrees of abduction completed at baseline, after 3 and 6 weeks of the training program.
Interventions
- OTHER Exercise
- DEVICE External Cueing Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-04-20 |
| Est. Completion | 2025-07-25 |
| Phase | NA |
What the finished NCT06923930 record still lists
NCT06923930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.
NCT06923930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06923930 about?
NCT06923930 is a clinical study titled "Impact of a Cueing Device on Upper Extremity Muscle Strength in Swimmers". The goal of this study is to find out if a tool called an external cueing device (ECD) can help young swimmers improve their shoulder function. An ECD is a tool that limits arm movement and gives the swimmer a target to focus on while doing exercises. The main questions this study will answer are: ...
What is the current status of trial NCT06923930?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2025-04-20. Estimated completion is 2025-07-25.
What interventions are being tested in trial NCT06923930?
The interventions under investigation include: Exercise (OTHER), External Cueing Device (DEVICE).
Who is sponsoring clinical trial NCT06923930?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06923930's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI